Takeda: Clinical trial disclosure (Rienso) — no breach, outwith scope (AUTH/2769/5/15) | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/2769/5/15
Parties	Paragraph 5.1/Director v Takeda
Issue	Clinical trial disclosure (Rienso)
Complaint received	14 May 2015
Completed	09 July 2015
Applicable Code year	2015
Decision	No breach; outwith the scope of the Code
Clauses cited	Not stated
Sanctions	Not stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

PMCPA Director considered a matter relating to clinical trial disclosure for Rienso involving Takeda.
The case was assessed under the ABPI Code applicable in 2015.

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →